Financial

iRhythm Technologies Announces Fourth Quarter and Full Year 2018 Financial Results and Provides Full Year 2019 Financial Outlook

SAN FRANCISCO, Feb. 12, 2019 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today reported financial results for the three months and full year ended December 31, 2018. Fourth Quarter and Full Year 2018 Highlights Revenue of […]

Endologix Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (Nasdaq: ELGX) (the “Company”), a developer and marketer of innovative treatments for aortic disorders, announced today the grant of inducement equity awards to eight newly hired employees (the “Awardees”). The awards were approved by the Company’s Compensation Committee, which is comprised of independent Directors, on January 31, 2019, […]

Merit Medical Systems to Announce Fourth Quarter and Year End Results and 2019 Guidance on February 26, 2019

SOUTH JORDAN, Utah, Feb. 12, 2019 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that it will release its financial results for the fourth quarter and year ended December 31, 2018 […]

OMEICOS Therapeutics Strengthens Board of Directors with the Appointment of Christian Schetter

BERLIN & BOSTON–(BUSINESS WIRE)–OMEICOS Therapeutics, a biopharmaceutical company developing first-in-class small molecule therapeutics for the prevention and treatment of cardiovascular and ophthalmic diseases, today announced the appointment of Christian Schetter, Ph.D., as an independent Board Member. Christian has over 20 years’ industry experience across the life sciences sector, and most […]

CardioMech Raises $2.5 Million in Heavily Oversubscribed Convertible Note

OSLO–(BUSINESS WIRE)–CardioMech AS announced today that it has closed on a convertible note financing of $2.5 million, which was significantly oversubscribed. The note included investments from experienced angel investors in interventional cardiology and structural heart disease. “This financing milestone demonstrates the rapid acceleration of the development of CardioMech’s transcatheter mitral valve repair technology. […]

FierceMedTech Names FineHeart as One of Its “Fierce 15” Med Tech Companies of 2018

BORDEAUX, France–(BUSINESS WIRE)–FineHeart today announced that it has been named by FierceMedTech as one of 2018’s Fierce 15 med tech companies, designating it as one of the most promising private med tech companies in the industry. FineHeart’s technology, the ICOMS (Implantable Cardiac Output Management System), is dedicated to the treatment of severe heart […]

Kardium Announces New Financing to Commercialize the Globe System for the Treatment of Atrial Fibrillation

VANCOUVER, British Columbia–(BUSINESS WIRE)–Kardium Inc., developer of the Globe® Mapping and Ablation System for the treatment of atrial fibrillation, announced today that it has raised an undisclosed amount in a new financing round. The financing was led by funds and accounts advised by T. Rowe Price Associates, Inc., and included participation from […]